Swiss National Bank Moon Lake Immunotherapeutics Transaction History
Swiss National Bank
- $137 Billion
- Q1 2025
A detailed history of Swiss National Bank transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Swiss National Bank holds 43,000 shares of MLTX stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,000
Previous 43,000
-0.0%
Holding current value
$1.7 Million
Previous $2.29 Million
26.48%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MLTX
# of Institutions
161Shares Held
55.3MCall Options Held
481KPut Options Held
229K-
Bvf Inc San Francisco, CA19.8MShares$782 Million33.91% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$336 Million35.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.97MShares$118 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$110 Million1.75% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.48MShares$58.5 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.46B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...